Melbourne scientists have discovered how tumour development is driven by mutations in the most important gene in preventing cancer, p53
Melbourne scientists have discovered how tumour development is driven by mutations in the most important gene in preventing cancer, p53.
The research revealed that in the early stages of cancer, mutant p53 'tackles' the normal p53 protein and blocks it from carrying out its protective role. As a result, p53 can no longer activate natural defences against cancer - such as the body's DNA repair process - increasing the risk of cancer developing.
The research was led by Dr Brandon Aubrey, Professor Andreas Strasser and Dr Gemma Kelly together with bioinformaticians Professor Gordon Smyth and Dr Yunshun Chen. The findings are published in this month's edition of Genes and Development.
At a glance
Tackling DNA's guardian
p53 is known as the 'guardian of the genome' due to its role in protecting cells from cancer.
"p53 plays a critical role in many pathways that prevent cancer, such as repairing DNA or killing cells if they have irreparable DNA damage," Dr Kelly said.
"Genetic defects in p53 are found in half of all human cancers, but exactly how these changes disrupt p53 function has long been a mystery."
Dr Kelly said that cells normally have two copies of the p53 gene in every cell.
"Early during cancer development, one copy of the gene may undergo a sudden and permanent change through mutation, while the other copy of the gene remains normal. This results in the cell making a mixture of normal and mutant versions of the p53 protein.
"We found that the mutant p53 protein can bind to and 'tackle' the normal p53 protein, blocking it from performing protective roles such as DNA repair. This makes the cell more likely to undergo further genetic changes that accelerate tumour development."
The team expected the mutant proteins would block all normal p53 activity, so was surprised to find that only certain p53-dependent pathways were affected.
"The mutant proteins are cunning: while they stop p53 from activating pathways that protect against cancer, they still allow p53 to activate pathways that promote tumour growth. p53's role in cancer is clearly more complicated than we had expected," Dr Kelly said.
A mystery resolved
Professor Strasser said the findings inform a longstanding debate about mutant p53.
"Scientists have been debating how mutant p53 contributes to the development of cancer for decades.
"One camp argues that mutant p53 acts by 'tackling' the normal protein and blocking its natural protective roles. The other camp argues that mutant p53 goes 'rogue' and performs new roles that promote tumour development."
"Our work clearly shows that during cancer development, the 'tackling' of normal p53 is most significant. This selectively disables certain but not all normal functions of p53," Professor Strasser said.
The team is now investigating whether the same is true for established tumours, with important implications for drug treatments.
"Established tumours have often lost the normal copy of their p53 gene and only produce mutant p53 protein," Dr Kelly said.
"If mutant p53 acts by tackling normal p53, then it may no longer play a role in established tumours where no normal p53 is produced. This would mean that drugs that block mutant p53 would have no clinical benefit," she said.
"Conversely, if mutant p53 has new, cancer-promoting activities of its own in established tumours, then a drug that specifically blocks mutant p53 could be beneficial for treating thousands of patients."
This work was supported by the Leukaemia Foundation, the Australian National Health and Medical Research Council, the Leukemia and Lymphoma Society of America, the Cancer Council of Victoria, the Victorian Cancer Agency, the Estate of Anthony (Toni) William Redstone OAM, the Craig Perkins Cancer Research Foundation, the Victorian State Government and the Australian Government.
Arunee Wilson | EurekAlert!
Doing More with Less: Stem Cells Regulate Their Fate by Altering Their Stiffness
14.01.2019 | Albert-Ludwigs-Universität Freiburg im Breisgau
Making ammonia 'greener'
14.01.2019 | Case Western Reserve University
The phenomenon of so-called superlubricity is known, but so far the explanation at the atomic level has been missing: for example, how does extremely low friction occur in bearings? Researchers from the Fraunhofer Institutes IWM and IWS jointly deciphered a universal mechanism of superlubricity for certain diamond-like carbon layers in combination with organic lubricants. Based on this knowledge, it is now possible to formulate design rules for supra lubricating layer-lubricant combinations. The results are presented in an article in Nature Communications, volume 10.
One of the most important prerequisites for sustainable and environmentally friendly mobility is minimizing friction. Research and industry have been dedicated...
Just in time for Christmas, a Mars-analogue mission in Morocco, coordinated by the Robotics Innovation Center of the German Research Center for Artificial Intelligence (DFKI) as part of the SRC project FACILITATORS, has been successfully completed. SRC, the Strategic Research Cluster on Space Robotics Technologies, is a program of the European Union to support research and development in space technologies. From mid-November to mid-December 2018, a team of more than 30 scientists from 11 countries tested technologies for future exploration of Mars and Moon in the desert of the Maghreb state.
Close to the border with Algeria, the Erfoud region in Morocco – known to tourists for its impressive sand dunes – offered ideal conditions for the four-week...
Research opens doors in photonic quantum information processing, optical signal processing and microwave photonics
Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed a new integrated photonics platform that can...
A team of experimentalists at the U.S. Department of Energy's Ames Laboratory and theoreticians at University of Alabama Birmingham discovered a remarkably long-lived new state of matter in an iron pnictide superconductor, which reveals a laser-induced formation of collective behaviors that compete with superconductivity.
"Superconductivity is a strange state of matter, in which the pairing of electrons makes them move faster," said Jigang Wang, Ames Laboratory physicist and...
Some patients with breast cancer receive chemotherapy before the tumor is removed with surgery. This approach, called 'neoadjuvant' therapy, helps to reduce the size of the tumor to facilitate breast-conserving surgery, and can even eradicate the tumor, leaving few or no cancerous cells for the surgeon to remove. In those cases, the patients are very likely to remain cancer-free for life after surgery.
But not all tumors shrink under chemotherapy. If the tumor resists neoadjuvant therapy, there can be a higher risk of developing metastatic disease, meaning...
14.01.2019 | Event News
12.12.2018 | Event News
10.12.2018 | Event News
14.01.2019 | Life Sciences
14.01.2019 | Event News
14.01.2019 | Physics and Astronomy